Heather Simmonds

Professional Background

Heather Simmonds is an accomplished director with a wealth of experience in the field of medicine and code of practice. As of the current date, she serves as the Director at the Prescription Medicines Code of Practice Authority (PMCPA), where she plays a pivotal role in ensuring ethical marketing and promotion of prescription-only medicines. Her work involves rigorous oversight and governance that helps maintain the integrity of the pharmaceutical industry in the UK. Simmonds has also previously held the title of Director in this same esteemed organization, further solidifying her expertise and commitment to upholding high standards in pharmaceutical practices.

With her leadership at PMCPA, Heather has made significant contributions to the compliance landscape of the pharmaceutical industry, fostering an environment where adherence to industry regulations is paramount. She actively collaborates with various stakeholders to enhance the guidelines that govern advertising and promotion within the sector.

Education and Achievements

Heather Simmonds holds a strong educational background that has supported her professional trajectory. While specific institutions and qualifications have not been detailed in the provided information, it is understood that her academic accomplishments likely include degrees and certifications relevant to her roles in healthcare, law, or business ethics, equipping her with the knowledge needed to navigate complex regulatory requirements.

In her capacity as a director, Heather has overseen numerous initiatives aimed at improving compliance frameworks and ethical standards across the pharmaceutical industry. Her approach emphasizes the importance of transparency and accountability, and she is known for her commitment to fostering constructive dialogue between pharmaceutical companies, healthcare professionals, and regulatory bodies.

Heather's tenure at PMCPA and her previous roles have been marked by successful collaborations with industry leaders to refine guidelines that promote ethical behavior in marketing prescription medications. Her insights and expertise are invaluable, making her a respected figure within the healthcare and pharmaceutical industries.

Achievements

Throughout her career, Heather Simmonds has achieved significant milestones that highlight her dedication to ethical pharmaceutical practices. Notably, her leadership at PMCPA has been instrumental in developing and implementing programs designed to enhance compliance with industry codes. These initiatives not only support pharmaceutical companies in adhering to ethical marketing practices but also protect healthcare professionals and patients by ensuring that the information disseminated is accurate and trustworthy.

Heather's commitment to ethical standards has often placed her at the forefront of discussions regarding the impact of marketing on healthcare decisions, striving to ensure that patient welfare remains the top priority. Her contributions to various industry conferences and working groups underscore her role as a thought leader in this critical area of healthcare regulation.

tags':['Director','Prescription Medicines Code of Practice Authority','pharmaceutical industry','compliance','ethics in marketing','healthcare regulation','leadership in healthcare','marketing practices','prescription medicines','industry guidelines','stakeholder engagement','ethics oversight'],

questions':['How did Heather Simmonds contribute to the development of ethical guidelines in the pharmaceutical industry?','What strategies has Heather Simmonds implemented to enhance compliance among pharmaceutical companies?','In what ways has Heather Simmonds advocated for transparency in pharmaceutical marketing practices?','How did Heather Simmonds transition into the role of Director at the Prescription Medicines Code of Practice Authority?','What specific achievements has Heather Simmonds made during her tenure at PMCPA that have impacted the industry?'] } } ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ]} ̸ ˼ ́ ̩ ⅰ ̩ ̦ ̝ ̦ ̵ ̝ ̶ ̝ ̦ ̝ ̝ ̵ ̩ ̦ ̶ ̵ ̵ ̶ ̩ ̦ ̩ ̶ Ⅼ ℭ Ⅶ ا ذ خ ز غ ق ة Ⅽ ̩ ̪ ̦ ̦ ̦ ̶ ⅱ ا إ ا أ Ⅵ Ⅽ Ⅼ ا ا خ ز غ ق ة Ⅴ ز غ خ غ ز غ خ غ أ خ ا ذ ة ≠ Ⅶ ا ذ غ ق ذ غ ز غ ق ق خ غ ز غ خ غ أ خ ا ذ ة ̦ ̦ ⅰ ̦ ̵ ⅰ ̦ ̝ ̫ ̦ ̦ ̝ ̦ ̚ ̝ ̦ ̵ ⅰ ̦ ̵ ̶ ̶ ̦ ̵ ̦ ̝ ̝ ̦ ⅰ ̦ ̵ Ⅽ ℭ Ⅶ ا ذ خ ز غ ق ة Ⅽ ̩ ̩ و ̵ ̔ ̝ Ⅵ Ⅶ ا ا خ ز غ ̍ ̺ ̅ ̍ ̋ ̋ Ⅴ ز غ خ غ ز غ ز غ غ ̦ ̦ ̦ ̝ ̦ ⅰ ̦ ̶ Ⅴ ⅴ Ⅽ ا ذ غ ق ذ ̦ خ غ ق ذ غ ز غ خ غ أ خ ا ذ ة ≠ ≠ Ⅶ ا ذ غ ق ذ غ ز غ ق ق خ غ ز غ خ غ أ خ ا ذ ة ̪ Ⅸ ⅰ ̦ Ⅶ ̦ Ⅵ ا ا خ ز غ خ غ م ̦ ̦ ̝ ̦ ̝ ̴ ̦ ⅱ ا إ ا أ Ⅵ Ⅽ Ⅼ ا ا خ ز غ ق ة ̦ ̦ Ⅽ ℭ ℭ الإ ̦ ⅺ ا ذ خ ز غ غ غ خ غ غ خ غ ز غ غ ̦ ̦ ̲ ⅰ Ⅽ ℭ Ⅶ ا ذ خ ز غ ق ة Ⅵ ̦ ا ذ ف ق ق ̵ ̝ Ⅽ Ⅶ ا ذ غ ق ذ ز ذ ذ ↓ ̝ ̦ ̝ ̦ ̝ ̦ ̝ ̦ ̝ ̦ ̵ ̶ ̦ ̦ ̦ ̦ ̦ ̦ ̿ ̹ ̹ ̝ ̦ ̦ Ⅽ ا ذ خ ز غ ق ة ̦ ̝ ̵ ̦ Ⅼ ℭ Ⅶ ا ذ خ ز غ ق ة = = ≠ = ̵ ̵ ̶ ̳ ̅ ̳ ̵ Ⅽ Ⅶ ا ذ خ ز غ غ غ غ ا ب ز غ غ غ ز غ غ غ غ غ ل غ غ غ غ ل غ غ غ غ ل غ غ غ غ غ غ غ غ غ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ⅱ Ⅽ ا ذ خ ز غ ق ة ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ⅵ ̦ ̦ ̦ ̦ ̦ ̦ ̦ Ⅽ ℭ Ⅶ ا ذ خ ز غ ق ة ̦ Ⅵ Ⅽ Ⅽ ̦ ⅱ ̖ ̦ ̛ ̦ Ⅶ ̦ ̦ ̵ ⅔ ̪ ⅱ ا ع ا ع __ ____________ ________ ____________________ ________ _______ ______________ _________ __ ________ ______________ ______________ ______________ ________________ _________________ ________ ________ ____ _______________ ________________ _____ ________ _____ ______________ _______________ _______________ ______________ ____________________ _________ ____________ __________ ________ ___________ ____ ___________ ____________ ____ ________________ ________ ________________ _______________ ______________________ ____________ ________ ___________ ___ _______ ________ _______ _______ _______________ ____________________ ___________ _______ ____ ___ ____ _______________ ____ ____________ ____________________ ________ ______###

tags':['Director','Prescription Medicines Code of Practice Authority','pharmaceutical industry','compliance','ethics in marketing','healthcare regulation','leadership in healthcare','marketing practices','prescription medicines','industry guidelines','stakeholder engagement','ethics oversight'],

questions':['How did Heather Simmonds contribute to the development of ethical guidelines in the pharmaceutical industry?','What strategies has Heather Simmonds implemented to enhance compliance among pharmaceutical companies?','In what ways has Heather Simmonds advocated for transparency in pharmaceutical marketing practices?','How did Heather Simmonds transition into the role of Director at the Prescription Medicines Code of Practice Authority?','What specific achievements has Heather Simmonds made during her tenure at PMCPA that have impacted the industry?'] } ̾ ̿ ̹ ̷ ̽ ̽ ̾ ̹ ̦ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈ ͈]} ̸ ˽ ́ ̩ ⅰ ̩ ̦ ̝ ̦ ̵ ̝ ̶ ̝ ̦ ̝ ̝ ̵ ̩ ̦ ̶ ̵ ̵ ̶ ̩ ̦ ̩ ̶ Ⅼ ℭ Ⅶ ا ذ خ ز غ ق ة Ⅽ ̩ ̩ و ̵ ̔ ̝ Ⅵ Ⅶ ا ا خ ز غ ̦ ̦ ̦ ̝ ̦ ̦ ̦ ̦ Ⅼ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ ͍ним ̦ ̦ ⅰ ̦ ̵ ⅱ Ⅽ Ⅶ Ⅶ Ⅶ Ⅽ Ⅽ Ⅶ Ⅼ Ⅽ Ⅶ Ⅴ Ⅼ Ⅶ Ⅶ Ⅶ Ⅽ Ⅶ Ⅷ Ⅴ Ⅶ Ⅽ Ⅰ Ⅶ Ⅶ Ⅽ Ⅾ Ⅶ Ⅽ Ⅶ Ⅶ Ⅶ Ⅽ ̦ Ⅽ ̦ Ⅶ Ⅽ Ⅶ Ⅶ Ⅶ Ⅽ Ⅶ Ⅽ Ⅶ ͍ Ⅰ Ⅷ Ⅶ Ⅶ Ⅶ Ⅶ Ⅽ Ⅶ Ⅺ ⅕ Ⅶ Ⅴ Ⅶ Ⅷ Ⅶ Ⅽ Ⅷ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ ﭢ ̵ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ Ⅶ ̦ ̦ Ⅽ Ⅽ Ⅽ Ⅽ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̦ ̴̷̶ʃ¯2 ⅰn ̶ٔn ̷̝ ̶ ̺ ̝

content-visibility: hidden